KNF approves NanoGroup IPO prospectus

The Financial Supervision Authority KNF approved the IPO prospectus of biotechnology company NanoGroup. The company’s majority shareholders include investment fund GPV (38 percent stake) and Tomasz Ciach (36 percent), the remaining shares are controlled by Startventure@Poland and other investors. The company will use the funds from the floating for research projects and hopes to raise…

This content is for Silver 6 months, Gold 1 Year and Bronze 2 weeks members only.
Log In Buy Subscription
Pin It